Searched for
MERCK LIMITED
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...- Empathy is not what you think it is—and that’s why it mattersEmpathy is not just awareness or intent. It is a deliberate leadership choice; to show up where others are, even when those spaces were not...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Tata Electronics, Merck sign MoU to boost semiconductor materials and infra in IndiaThe companies have come to an understanding whereby Merck will offer its full suite of products and services, including high-purity electro...
- Verona Pharma stock jumps 20% on $10B Merck deal—can FDA-approved Ohtuvayre reshape COPD care?Verona Pharma stock jumped 20% after Merck announced it will acquire the British biotech in a $10 billion deal. Merck will pay $107 per sha...
- How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
- Aurobindo Pharma launches COVID-19 drug Molnupiravir in IndiaMolnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, a press release from the city-based d...
- UK authorizes Merck's coronavirus pill, the first shown to be effective at treating COVID-19The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe...
- Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravirNatco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. "We have submitted p...
- Lupin gets USFDA nod to market skin ointmentThe product will be manufactured at the company's Pithampur, Unit 3 facility, Lupin said in a filing to the BSE. The approval by the United...
- Buy Merck, target Rs 1,220: Shrikant ChouhanBuy Merck Ltd. at a price target of Rs 1,220 and a stop loss at Rs 1,105 from entry point.
- Merck launches new generation pigments in IndiaThe Merck Group subsidiary Merck Limited said it has launched Meoxal Taklamakan Gold pigment for auto and plastic coatings industry.
- Merck KGaA acquires Bangalore-based bioscience companyMerck KGaA today announced the acquisition of Bangalore Genei (India) Private Limited by its wholly-owned subsidiary in India, Merck Specia...
- Merck buys Schering-Plough in $41.1b cash-&-stock dealUS-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.
- Merck buys Schering-Plough for $41 bn to access new drugsUS-based Merck & Co on Monday said it is acquiring Schering Plough for $41.1 bn in a cash-and-stock deal to create a $42-bn drug major.
- Merck Generics valuation to be hit as Duoneb patent endsMerck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...
- Ranbaxy sees synergy dose in Merck unitRanbaxy’s reported interest in the Merck KGaA’s generic division has the potential of being one of the most synergistic acquisitions in rec...
- Vioxx lawsuits pile up in US courtsA Surge of lawsuits has swamped courthouses just ahead of the two-year anniversary of drugmaker Merck pulling its blockbuster painkiller Vi...
- Merck wins one more Vioxx caseVioxx-maker Merck faces thousands of lawsuits nationwide over the once-popular painkiller, but the pharmaceutical giant’s strategy to fight...
Load More
